Pricing Log in Create free account

Anbio Biotechnology (NNNN) vs Pro-Dex, Inc. (PDEX)

Anbio Biotechnology and Pro-Dex, Inc. are both Medical Instruments & Supplies companies. Anbio Biotechnology is the larger, with a market value of $516.6M against $195.8M — 2.6× the size. Across the 9 metrics below, Pro-Dex, Inc. leads on 5 and Anbio Biotechnology on 4.

Valuation

Metric NNNN PDEX Medical Instruments & Supplies median
P/E — 16.81 30.84
P/S — 2.54 2.54
P/B n/m 4.10 2.36
Price to free cash flow n/m 18.96 23.46
EV/EBITDA n/m 13.52 14.70
EV/Sales n/m 2.53 2.78
Earnings yield — 5.95% 0.25%
Free cash flow yield 0.00% 5.27% 0.57%

Profitability

Metric NNNN PDEX Medical Instruments & Supplies median
Gross margin — 32.45% 53.46%
Operating margin — 16.84% 2.26%
Net margin — 15.12% 0.16%
Free cash flow margin 0.00% 13.43% 4.10%
Return on equity 0.00% 26.48% 0.00%
Return on assets 0.00% 17.08% 0.00%
Return on invested capital 0.00% 17.22% 0.13%

Growth

Metric NNNN PDEX Medical Instruments & Supplies median
Revenue growth (TTM) — 13.31% 8.97%
EPS growth (last fiscal year) 150.00% 54.31% 6.51%
Revenue growth, 5-year CAGR — 15.32% 8.85%
Net income growth, 5-year CAGR — 17.23% 0.00%

Health

Metric NNNN PDEX Medical Instruments & Supplies median
Debt to equity 0.00 0.25 0.10
Current ratio 344.45 4.19 2.42
Net debt to EBITDA (2.06) 0.27 0.97

Dividend

Metric NNNN PDEX Medical Instruments & Supplies median
Dividend yield — — 1.03%
Payout ratio — — 0.25

Size

Metric NNNN PDEX Medical Instruments & Supplies median
Market cap 516.57m 195.84m 1.64b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack